Related references
Note: Only part of the references are listed.Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Detection of BRAF p.V600E Mutations in Melanomas Comparison of Four Methods Argues for Sequential Use of Immunohistochemistry and Pyrosequencing
Emeline Colomba et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
David Capper et al.
ACTA NEUROPATHOLOGICA (2012)
Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma
Oskar Koperek et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
Molly Yancovitz et al.
PLOS ONE (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
The Dermoscopical and Histopathological Patterns of Nevi Correlate with the Frequency of BRAF Mutations
Iris Zalaudek et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Lyndee L. Scurr et al.
CELL (2010)
Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7-challenging the concept of dysplastic nevi as precursor lesions?
Kristen DeCarlo et al.
HUMAN PATHOLOGY (2010)
Lack of Correlation between IGFBP7 Expression and BRAF Mutational Status in Melanoma
David Schrama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Allelotyping, Microsatellite Instability, and BRAF Mutation Analyses in Common and Atypical Melanocytic Nevi and Primary Cutaneous Melanomas
Pablo Uribe et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2009)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma
Victoria R. Greene et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Progression of NRAS and BRAF Mutations in Cutaneous Melanoma
Ritchie Rosso et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: Implications for melanocytic tumorigenesis
Julie Wu et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2007)
BRAF and NRAS mutations in melanoma and melanocytic nevi
Jenny N. Poynter et al.
MELANOMA RESEARCH (2006)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
BRAF somatic mutations in malignant melanoma and melanocytic naevi
NE Thomas
MELANOMA RESEARCH (2006)
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
Vikas K. Goel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi
T Papp et al.
MELANOMA RESEARCH (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues
MR Hussein
JOURNAL OF CLINICAL PATHOLOGY (2005)
BRAF kinase gene V599E mutation in growing melanocytic lesions
R Loewe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Cutaneous melanomas associated with nevi
C Bevona et al.
ARCHIVES OF DERMATOLOGY (2003)
BRAF mutation -: A frequent event in benign, atypical, and malignant melanocytic lesions of the skin
P Uribe et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2003)
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma - A population-based estimate
H Tsao et al.
ARCHIVES OF DERMATOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
A genome-based strategy uncovers frequent BRAF mutations in melanoma
PM Pollock et al.
CANCER CELL (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma
A Demunter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Share Paper
